Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MNPR · NASDAQ · Pharmaceutical Preparations
Monopar Therapeutics (MNPR) · oqro.io/stocks/MNPR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$69.00−1.29 (−1.84%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 2, 2026 · Filed Nov 5, 2026
Director sold ~$105K of MNPR shares in the open marketSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Director sold ~$92K of MNPR shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 5, 2026
Director sold ~$84K of MNPR shares in the open marketSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Director sold ~$71K of MNPR shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 5, 2026
Director sold ~$56K of MNPR shares in the open marketSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Director sold ~$43K of MNPR shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 5, 2026
Director sold ~$40K of MNPR shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 5, 2026
Director sold ~$14K of MNPR shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 6, 2026
Director sold ~$362K of MNPR shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 6, 2026
Director sold ~$234K of MNPR shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 6, 2026
Director sold ~$64K of MNPR shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 29, 2026
CEO sold ~$911K of MNPR shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 29, 2026
CEO sold ~$848K of MNPR shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 29, 2026
CEO sold ~$745K of MNPR shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 29, 2026
CEO sold ~$54K of MNPR shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a new position in MNPR for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deerfield Management Company, L.P. disclosed an increased position in MNPR for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in MNPR for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ra Capital Management, L.P. disclosed an increased position in MNPR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a new position in MNPR for Q4 2025SourceInsider trade · Traded Sep 24, 2025 · Filed Sep 26, 2025
10% owner sold ~$35M of MNPR shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 17, 2025
CEO sold ~$672K of MNPR shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 17, 2025
Director sold ~$672K of MNPR shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 17, 2025
Director sold ~$356K of MNPR shares in the open marketSourceInsider trade · Traded Apr 2, 2025 · Filed Apr 4, 2025
10% owner sold ~$1.17M of MNPR shares in the open marketSourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
CFO purchased ~$25K of MNPR shares in the open marketSource